Skip to main content

« All Events

Mochida Open Innovation Research (MOIRe) program applications

July 31

MOIRe logo Mochida

Since 2019, we [Mochida Pharmaceuticals] have implemented MOIRe, our open innovation program for drug discovery research based on proposals from academic researchers. We welcome applications from researchers with a great interest in connecting drug discovery seeds to pharmaceutical development.

MOIRe：Mochida Open Innovation Research
Moire means ripple and contains our hope that “We want to create new drugs for broad clinical use starting from promising seeds,” like the ripples from water droplets.

Research Topics for “MOIRe”

  • We invite your proposals for research collaboration on the following research topics this year.
  • Click the button below for displaying the details of each research topics.

FY2023 Application Guidelines

Applicant Researchers and research representatives affiliated with public research institutions, universities, etc.
Also including researchers in university-originated venture companies.
 

Interest areas

  

  • Intractable, Rare or Refractory diseases
  • Drug development technologies
Research proposals  

We invite your proposals for collaborative research relating to drug candidates or targets for intractable, rare or refractory diseases focusing on therapeutic modalities of stem cell drugs, oligonucleotide therapeutics or gene therapy.
We also invite your proposals for collaborative research relating to technologies of stem cell drugs, oligonucleotide therapeutics or gene therapy.
For more information, please refer to the research topics for each area.
Research period  

One year in principle

 
Research expenses  

Maximum US$ 50,000 / project
・For researchers affiliated with institutions in Japan, maximum 5,000,000 yen / project（excluding tax）.
・The amount is decided for each project after consultation.

 
Application form  

Please download the application documents from the link below.

 
Application method
  • Please submit the application documents with the necessary information to the dedicated email address(moire.info@mochida.co.jp). In the subject of the email, please specify your institution and applicant name, as in “MOIRe_institution_applicant name”.
  • The application documents should only contain non-confidential information. Please understand that if unpublicized information is included, we cannot take responsibility for maintaining confidentiality and protecting intellectual property rights.
  • Your personal information will not be used for any purposes other than to contact you in connection with the application. Please see “Handling of Personal Information Open new window” on our website for our policy on the handling of personal information.
Application period  

June 1, 2023 to July 31, 2023

 
Selection
First selection:
Reviews based on application documents
The selection results will be notified by email by end of September 2023.
Second selection:
Reviews by interview
We will conclude a non-disclosure agreement if necessary.
Collaborative research agreement  

The collaborative research proposals adopted in the final selection will commence after the conclusion of a collaborative research agreement with your research institution.

 
Notes
  • We will not select research proposals that have already been supported by other companies as collaborative research.
  • Please note that we will not respond to inquiries about the facts, contents, and selection status of the application.
Contact us  

Please direct inquiries to the dedicated email address. moire.info@mochida.co.jp

 

Details

Date:
July 31
Event Category:
Event Tags:
, ,
Website:
https://www.mochida.co.jp/english/business/rd_openinnovation.html

Organizer

Mochida Pharmaceuticals
View Organizer Website

Venue

Online

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us